Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
Parke-Davis, the pharmaceutical division of Warner-Lambert, is reviewing two consumer ad accounts. A $35 million assignment for anti-cholesterol brand Lipitor and the $15 million business of diabetes drug Rezulin are in play, sources said.
Both reviews are being overseen by Bob Ehrlich, senior director of direct-to-consumer communications in Morris Plains, N.J., sources said. Ehrlich is in talks with W-L roster shops J. Walter Thompson and Bates USA, both New York, as well as nonroster agencies, for Lipitor.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in